SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. ALAR
3. SPY
4. CCH:LN
5. META
6. CCHGY
7. PRY:IM
8. PRYMY
9. SKA-B
10. PBA

Go back to SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes
(NASDAQ: SABS) Delayed: 3.92 +0.04 (1.03%)
Previous Close $3.88    52 Week High $ 
Open $3.91    52 Week Low $ 
Day High $4.04    P/E N/A 
Day Low $3.85    EPS $ 
Volume 266,615       

(NASDAQ: SABSW) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $ 
Open $0.01    52 Week Low $ 
Day High $0.01    P/E N/A 
Day Low $0.01    EPS $ 
Volume 100,220